These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 20466543

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain.
    Cornford EM, Young D, Paxton JW, Finlay GJ, Wilson WR, Pardridge WM.
    Cancer Res; 1992 Jan 01; 52(1):138-43. PubMed ID: 1727374
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Site-directed mutagenesis of rabbit LAT1 at amino acids 219 and 234.
    Boado RJ, Li JY, Pardridge WM.
    J Neurochem; 2003 Mar 01; 84(6):1322-31. PubMed ID: 12614332
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer.
    Lu X.
    Curr Cancer Drug Targets; 2019 Mar 01; 19(11):863-876. PubMed ID: 31376820
    [Abstract] [Full Text] [Related]

  • 14. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition.
    Uchino H, Kanai Y, Kim DK, Wempe MF, Chairoungdua A, Morimoto E, Anders MW, Endou H.
    Mol Pharmacol; 2002 Apr 01; 61(4):729-37. PubMed ID: 11901210
    [Abstract] [Full Text] [Related]

  • 15. L-type amino acid transporter 1 utilizing prodrugs: How to achieve effective brain delivery and low systemic exposure of drugs.
    Puris E, Gynther M, Huttunen J, Petsalo A, Huttunen KM.
    J Control Release; 2017 Sep 10; 261():93-104. PubMed ID: 28662899
    [Abstract] [Full Text] [Related]

  • 16. Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan.
    Kühne A, Kaiser R, Schirmer M, Heider U, Muhlke S, Niere W, Overbeck T, Hohloch K, Trümper L, Sezer O, Brockmöller J.
    Pharmacogenet Genomics; 2007 Jul 10; 17(7):505-17. PubMed ID: 17558306
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line.
    Takahashi Y, Nishimura T, Higuchi K, Noguchi S, Tega Y, Kurosawa T, Deguchi Y, Tomi M.
    Pharm Res; 2018 Oct 29; 35(12):246. PubMed ID: 30374619
    [Abstract] [Full Text] [Related]

  • 19. L-Type amino acid transporter 1 as a target for drug delivery.
    Puris E, Gynther M, Auriola S, Huttunen KM.
    Pharm Res; 2020 May 06; 37(5):88. PubMed ID: 32377929
    [Abstract] [Full Text] [Related]

  • 20. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
    Yan R, Zhao X, Lei J, Zhou Q.
    Nature; 2019 Apr 06; 568(7750):127-130. PubMed ID: 30867591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.